Global Pharmaceutical Filtration Market Trends, Forecast Report 2025-2037
Pharmaceutical Filtration Market size is set to grow from USD 13.33 billion to USD 88.97 billion, demonstrating a CAGR of around 15.5% during the forecast timeline, between 2025 and 2037. In the year 2025, the industry size of pharmaceutical filtration is evaluated at USD 15 billion.
The market growth is attributed to growing number of new drugs, and positive trends in spending for drug research and development (R&D) worldwide. According to the statistics presented by the Congressional Budget Office, in the year 2019, the U.S. pharmaceutical industry invested USD 83 billion in R&D.
Pharmaceutical filtration is a process of removing solid particulate matter from a fluid in the form of liquid or gas. A porous medium is used for this process. As the biopharmaceutical market is highly regulated and new means are annexed consistently to reduce wastage, the process of filtration is used widely in pharmaceutical industries. Global oharmaceutical filtration market size is guaranteed to flourish as the filtration process is considered to be omnipresent with the increased spending for R&D in the pharmaceutical industry along with introduction of new drugs at a faster pace.
Pharmaceutical wastages are expected to create significant revenue generation for the key players operating in the global pharmaceutical filtration market. It is estimated that more than 100,000 ton of pharmaceutical products are consumed globally each year, with Europe accounting for 24% of that total consumption. Active Pharmaceutical Ingredients (API) and other chemical ingredients are released into the environment during the manufacturing, usage, and disposal of these pharmaceutical products, causing pharmaceutical pollution worldwide.
Pharmaceutical Filtration Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Investment in Biopharmaceutical Research and Development - A very small patient group of people can receive approved medications. Biopharmaceutical companies work hard to produce high-quality pharmaceuticals that patients get for a long time. According to the International Federation of Pharmaceutical Manufacturers & Associations, it is estimated that USD 179 billion was spent globally on the biopharmaceutical industry R & D in 2018. The aggregate contribution from the combined, direct, indirect, and induced effects of the biopharmaceutical industry was USD 1,838 billion to the world’s GDP.
- Upsurge in the Use of Active Pharmaceutical Ingredients (API) – Globally, China produces approximately 75 to 85% of antibiotic APIs whilst Indian companies are leading in the production of finished products.
- Rise in the Utilization of Single-Use Technologies & Systems in the Biopharmaceutical Industry – It was found that single-use bioreactors grew by approximately 59% points over the past 13 years.
- Surge in the Profitability of Large Pharmaceutical Companies - it was observed that, from 2000 to 2018, the cumulative revenue of 35 large pharmaceutical companies was approximately USD 11.5 trillion, with gross profit of more than USD 8.5 trillion, earnings before interest, taxes, depreciation, and amortization (EBITDA) of USD 3.5 trillion, and net income of USD 2 trillion.
- Upsurge in Nanofiltration Membrane Market - in the year 2020, the U.S. nanofiltration market was estimated to be USD19 Million.
Challenges
- Upsurge of Fiber Breakage in Membrane Filters - Pharmaceutical manufacturing facilities frequently fail to filter out all of the chemicals employed in the process, which causes the chemicals to leak into nearby freshwater systems before finally reaching the sea, lakes, streams, and rivers. In China, the polymeric membrane was already widely used to purify drinking water, with just a maximum treatment capacity of 3.8 million tonnes.
- Negative Impact of Active Pharmaceutical Ingredients (API) on Human Health and the Ecosystem
- High Cost Involved in the Installation and Upgradation of the Filtration System
Pharmaceutical Filtration Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
15.5% |
|
Base Year Market Size (2024) |
USD 13.33 billion |
|
Forecast Year Market Size (2037) |
USD 88.97 billion |
|
Regional Scope |
|
Pharmaceutical Filtration Segmentation
Membrane Type (Microfiltration, Ultrafiltration, Nanofiltration)
The microfiltration segment in the pharmaceutical filtration market is poised to account for largest share by 2037, backed by increasing demand for sterile water along with surge of cold sterilization of pharmaceutical industries. It was observed that in the year 2021, the estimated revenue generation of microfiltration membranes accounted for approximately USD 3 billion.
Our in-depth analysis of the global market includes the following segments:
|
By Filtration Method |
|
|
By Product Type |
|
|
By Membrane Type |
|
|
By Application |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPharmaceutical Filtration Industry - Regional Synopsis
North America pharmaceutical filtration market is predicted to account for largest revenue share by the end of 2037, propelled by increasing demand for pharmaceuticals owing to the rising burden of various types of diseases and other health conditions in the region. It was found that the use of pharmaceuticals in the United States has risen 9.5% over the last five years to approximately 194 Bn days of therapy including retail and non-retail settings in the year 2021.
Companies Dominating the Pharmaceutical Filtration Landscape
- 3M
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amazon Filters Ltd.
- Parker-Hannifin Corporation
- Sartorius
- Eaton Corporation plc
- Graver Technologies LLC
- Meissner Filtration Products, Inc.
- Cole-Parmer Instrument Company, LLC.
- Donaldson Company, Inc.
- Danaher Corporation
In the News
-
Amazon Filters Ltd. announced the launch of a new range of filter housings, single-stack 72C, and 76C series, to support critical processes in the production of biopharmaceuticals. The series conforms to the newest iteration standard of the industry-leading ASME BPE, fulfilling its criteria required for hygienic design, fabrication, and material construction.
-
Sartorius’s subgroup Sartorius Stedim Biotech, acquired U.S.-based filtration and purification expert WaterSep BioSeparations LLC. The acquisition brought in fresh crossflow filtration units for easy-to-use bioprocessing devices and is a complementary fit to the company’s separation portfolio.
Author Credits: Radhika Pawar
- Report ID: 491
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
